To ensure that Pediatric Chemotherapy/Biotherapy Providers stay current in their knowledge of safe chemotherapy and biotherapy administration, APHON requires active Providers to renew their status every three years. This is an important part of the Pediatric Chemotherapy/Biotherapy Provider Program which allows all Providers to keep pace with the ever changing advancement in medicine and technology.
This online program asks participants to read updated administration material, take a posttest, and complete an evaluation. Upon successful completion, participants will be awarded 2 continuing nursing education (CNE) credits.
Content of the Program
- Emerging Therapies in Pediatric Oncology
- Typhlitis and Sinusoidal Obstruction Syndrome as Treatment-Associated Toxicities
- Medication Adherence in Childhood Acute Lymphoblastic Leukemia
- Care of the Patient Receiving Radiation Therapy
The renewal exam consists of 25 questions and you must achieve a minimum score of 80% to pass. If you are unsuccessful on your first attempt, you will be permitted to retake the exam one time at no additional cost. If you do not achieve a passing score after two attempts you will be required to take the 2-day provider course again.
As a result of participating in this educational activity, the learner will gain the specific knowledge, according to national standards, that is needed to safely and consistently administer chemotherapy and biotherapy to children and adolescents. The measurement of this outcome will be evidenced by post testing and evaluations.
The dates for provider renewals are as follows (please refer to your provider card for the issue date):
Provider Card Issue Date
Renewal Fee Structure
2017 Provider Renewal
Provider Renewal Policies
How are Pediatric Chemotherapy/Biotherapy providers notified that they are due to renew their status?
APHON will try to contact Providers in advance of the renewal deadlines, but providers are responsible for maintaining their own status.
When are pediatric Chemotherapy/Biotherapy providers eligible to renew their status?
Providers are not eligible to renew nor will they be able to access the posttest until approximately 8 weeks prior to their expiration date.
How much time do I have to complete the Pediatric Chemotherapy/Biotherapy renewal exam once I start?
You will have 90 minutes to complete the 25 question exam. The timer does not begin until you click the “Renewal Exam” button. You must achieve a minimum score of 80% to pass. If you are unsuccessful on your first attempt, you will be permitted to retake the exam at no additional cost. If you do not achieve a passing score after two attempts you will be required to take the 2-day provider course again.
When is the deadline to complete the pediatric chemotherapy/biotherapy renewal exam?
The exam must be completed by 11 pm Central Time on December 31, 2017.
Note: Staff support will not be available to provide assistance with technical issues on Saturday, December 30 or on Sunday, December 31. We strongly encourage all providers to initiate the renewal process during normal business hours no later than Friday, December 29 when staff will be available to provide support. Exceptions will not be given to providers that experience technical difficulties on Saturday, December 30 or Sunday, December 31.
You will not be permitted to take the exam after 11 pm Central Time, December 31, 2017 regardless if payment was submitted nor will a refund be given. Additionally, no refunds will be given for failure to complete the exam by December 31, 2017 or failure to achieve a passing score on the exam.
How do Pediatric Chemotherapy/Biotherapy Providers that previously completed the exam access their continuing nursing education certificate?
Providers that previously completed the renewal process may access their CNE certificate by logging into their APHON website account. Users will be required to login using their APHON website ID and password.
What is the refund/cancellation policy?
All orders are final once payment is submitted. APHON reserves the right to refuse to refund duplicate payments submitted for the provider renewal exam. We strongly encourage providers verify previous payment submission prior to completing the renewal exam purchase.
Accreditation and Disclaimer
This program may be also recognized for the amount of 0.34 hours of pharmacology content indicated as calculated by the APHON Pediatric Chemotherapy/Biotherapy Provider Program Committee. APHON does not award pharmacology credit. APHON recommends that attendees retain a copy of the certificate for supportive documentation to submit to your state’s nursing board. Please note that you may not apply CNE toward pharmacology content. The content may be applied in only one area, nursing contact hours or pharmacology content.
Official ONCC Statement and Disclaimer
The program content has been reviewed by the Oncology Nursing Certification Corporation (ONCC) and is acceptable for recertification points.
- Treatment Modalities
- Preparative Regimens and Stem Cell Infusion
ONCC review is only for designating content to be used for recertification points and is not for CNE accreditation. CNE programs must be formally approved for contact hours by an acceptable accreditor/approver of nursing CE to be used for recertification by ONCC. If the CNE provider fails to obtain formal approval to award contact hours by an acceptable accrediting/approval body, no information related to ONCC recertification may be used in relation to the program. Have questions regarding the CPHON® ILNA Coding? Please visit the ONCC website or call them toll-free at 877.769.ONCC (US and Canada only)
The Association of Pediatric Hematology/Oncology Nurses (APHON) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
A staff member, volunteer, or family member who has an affiliation with a commercial company must declare that relationship in advance of involvement with an education activity that could be used as a forum to promote the interest of that company and its products. There are no disclosures to report for this activity.